RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Patricia B. Rockwell and Maria Figueiredo-Pereira.
  1. Figueiredo-Pereira ME, Serrano PA, Rockwell P. Six promising drug repurposing candidates for Alzheimer's disease and their sex-specific mechanisms and efficacy. Neural Regen Res. 2025 Aug 13.
    View in: PubMed
    Score: 0.961
  2. Ndukwe K, Serrano PA, Rockwell P, Xie L, Figueiredo-Pereira ME. Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model. J Alzheimers Dis. 2025 Mar; 104(1):173-190.
    View in: PubMed
    Score: 0.232
  3. Birnbaum EM, Xie L, Serrano P, Rockwell P, Figueiredo-Pereira ME. BT-11 repurposing potential for Alzheimer's disease and insights into its mode of actions. bioRxiv. 2024 Oct 29.
    View in: PubMed
    Score: 0.228
  4. Wallace CH, Oliveros G, Xie L, Serrano P, Rockwell P, Figueiredo-Pereira M. Potential Alzheimer's early biomarkers in a transgenic rat model and benefits of diazoxide/dibenzoylmethane co-treatment on spatial memory and AD-pathology. Sci Rep. 2024 02 14; 14(1):3730.
    View in: PubMed
    Score: 0.217
  5. Ndukwe K, Serrano PA, Rockwell P, Xie L, Figueiredo-Pereira M. Histone deacetylase inhibitor RG2833 has therapeutic potential for Alzheimer's disease in females. bioRxiv. 2023 Dec 29.
    View in: PubMed
    Score: 0.215
  6. Chaudry O, Ndukwe K, Xie L, Figueiredo-Pereira M, Serrano P, Rockwell P. Females exhibit higher GluA2 levels and outperform males in active place avoidance despite increased amyloid plaques in TgF344-Alzheimer's rats. Sci Rep. 2022 11 09; 12(1):19129.
    View in: PubMed
    Score: 0.199
  7. Wallace CH, Oliveros G, Serrano PA, Rockwell P, Xie L, Figueiredo-Pereira M. Timapiprant, a prostaglandin D2 receptor antagonist, ameliorates pathology in a rat Alzheimer's model. Life Sci Alliance. 2022 09 27; 5(12).
    View in: PubMed
    Score: 0.197
  8. Figueiredo-Pereira ME, Li Z, Jansen M, Rockwell P. N-acetylcysteine and celecoxib lessen cadmium cytotoxicity which is associated with cyclooxygenase-2 up-regulation in mouse neuronal cells. J Biol Chem. 2002 Jul 12; 277(28):25283-9.
    View in: PubMed
    Score: 0.192
  9. Wang H, Cheung F, Stoll AC, Rockwell P, Figueiredo-Pereira ME. Mitochondrial and calcium perturbations in rat CNS neurons induce calpain-cleavage of Parkin: Phosphatase inhibition stabilizes pSer65Parkin reducing its calpain-cleavage. Biochim Biophys Acta Mol Basis Dis. 2019 06 01; 1865(6):1436-1450.
    View in: PubMed
    Score: 0.153
  10. Jean-Louis T, Rockwell P, Figueiredo-Pereira ME. Prostaglandin J2 promotes O-GlcNAcylation raising APP processing by a- and ?-secretases: relevance to Alzheimer's disease. Neurobiol Aging. 2018 02; 62:130-145.
    View in: PubMed
    Score: 0.141
  11. Figueiredo-Pereira ME, Rockwell P, Schmidt-Glenewinkel T, Serrano P. Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration. Front Mol Neurosci. 2014; 7:104.
    View in: PubMed
    Score: 0.115
  12. Li Z, Arnaud L, Rockwell P, Figueiredo-Pereira ME. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells. J Neurochem. 2004 Jul; 90(1):19-28.
    View in: PubMed
    Score: 0.056
  13. Oliveros G, Wallace CH, Chaudry O, Liu Q, Qiu Y, Xie L, Rockwell P, Figueiredo-Pereira ME, Serrano PA. Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. Brain. 2023 03 01; 146(3):898-911.
    View in: PubMed
    Score: 0.051
  14. Avila JA, Kiprowska M, Jean-Louis T, Rockwell P, Figueiredo-Pereira ME, Serrano PA. PACAP27 mitigates an age-dependent hippocampal vulnerability to PGJ2-induced spatial learning deficits and neuroinflammation in mice. Brain Behav. 2020 01; 10(1):e01465.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support